CD40LG and Insulin resistance: In animal studies on insulin resistance, the genetic or antibody-mediated disruption of CD40L signaling have been shown to counteract the diet effects on fat liver amount, adipose tissue increase, and insulin resistance, by acting on liver very low-density lipoprotein (VLDL) release and genes adjusting lipid metabolism [58].